Compare Gemini Space Station Inc (GEMI) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs IDEXX Laboratories, Inc. — how do they compare? Gemini Space Station Inc trades at $4.4 (market cap $579.55M), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 69.8× Gemini Space Station Inc's market cap, and IDEXX Laboratories, Inc. is more actively traded (692,164 versus 1,882,406). Which is the better fit depends on your goals — on Pluang, investors hold Gemini Space Station Inc for 14 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| GEMI | IDXX | |
|---|---|---|
Market Cap | $579.55M | $40.43B |
Volume | 1,882,406 | 692,164 |
Sector | Financials | Health |
52-Week High | $23.45 | $766.68 |
52-Week Low | $3.54 | $504.70 |
Typical Hold Time | 14 Days | 46 Days |
Enterprise Value | $558.57M | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.47, down 0.45% with a bearish technical outlook. The company reported Q2 2026 revenue growth of 37% year-over-year to $207 million but continues to post significant losses with a net income margin of -250.13%. Recent news highlights expansion into commission-free stock trading and prediction markets, though the stock faces class action lawsuits and mixed analyst sentiment.
Investment outlook remains cautious due to persistent unprofitability and legal challenges. The consensus price target of $5.25 offers 17% upside potential, but high cash burn and negative margins pose substantial risks. Wall Street is divided with 33% buy ratings amid ongoing operational challenges and competitive pressures in financial services.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
